Skip to main content
Clinical Trials/NCT00835874
NCT00835874
Terminated
Not Applicable

Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis

Tel-Aviv Sourasky Medical Center1 site in 1 country57 target enrollmentJune 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Necrotizing Enterocolitis
Sponsor
Tel-Aviv Sourasky Medical Center
Enrollment
57
Locations
1
Primary Endpoint
all cause mortality at three months of age
Status
Terminated
Last Updated
13 years ago

Overview

Brief Summary

We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.

Detailed Description

Oral probiotics have previously been shown to prevent necrotizing enterocolitis in preterm infants. A few reports of sepsis by a probiotic bacteria have impeded implementation of oral probiotic supplementation in most NICUs. Considering the proven immunomodulatory effect of maternal probiotics on breastfed infants of atopic mothers, we would like to explore the indirect effects of maternal probiotics on preterm infants

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
July 2009
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Mothers of preterm infants
  • Pumping breast milk

Exclusion Criteria

  • Neonatal congenital anomalies

Outcomes

Primary Outcomes

all cause mortality at three months of age

Time Frame: 3 months

incidence and severity of necrotizing enterocolitis by Bell's staging at Three months

Time Frame: 3 months

occurrence of bacterial or fungal infection per blood,csf or urine cultures at three months

Time Frame: 3 months

Secondary Outcomes

  • maternal adverse effects during treatment(3 months)
  • incidence of BPD, PVL, ROP(36 weeks)

Study Sites (1)

Loading locations...

Similar Trials